Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)
China · Delayed Price · Currency is CNY 72.61
+0.61 (0.85%)
At close: Sep 18, 2026
SHA:688198 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 625.98 | 620.15 | 501.88 | 370.64 | 295.17 | 251.82 |
Revenue Growth | 11.94% | 23.57% | 35.41% | 25.57% | 17.21% | 38.42% |
Gross Profit Gross Profit Growth | 558.65 | 553.06 | 443.35 | 333 | 263.81 | 222.21 |
Operating Income Operating Income Growth | 148.34 | 186.6 | 131.86 | 99.5 | 82.17 | 30.17 |
Net Income Net Income Growth | 166.06 | 193.57 | 146.33 | 115.21 | 95.13 | 51.2 |
Earnings Per Share EPS Growth | 1.21 | 1.41 | 1.07 | 0.84 | 0.70 | 0.38 |
EPS Growth | -8.67% | 31.78% | 27.38% | 20.00% | 84.21% | -9.82% |
| Fiscal Year | TTM | FY 2025 |
|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 |
Medical Instruments Medical Instruments Growth | 623.46 | 617.64 |
Others Others Growth | - | 0.14 |
Total Total Growth | 623.6 | 617.78 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 387.78 | 594.52 | 370.04 | 535.62 | 612.91 | 772.31 |
Total Debt Total Debt Growth | 59.23 | 93.62 | 9.79 | 12.29 | 1.4 | 1.66 |
Net Cash (Debt) Net Cash Growth | 328.55 | 500.91 | 360.26 | 523.33 | 611.51 | 770.65 |
Net Cash Growth | 40.14% | 39.04% | -31.16% | -14.42% | -20.65% | 1.15% |
Net Cash Per Share Net Cash Per Share Growth | 2.39 | 3.65 | 2.63 | 3.82 | 4.50 | 5.72 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 123 | 197.79 | 136.23 | 141.17 | 128.85 | 76.49 |
Capital Expenditures CapEx Growth | -110.17 | -136.2 | -163.26 | -128.63 | -104.83 | -72.22 |
Free Cash Flow Free Cash Flow Growth | 12.83 | 61.6 | -27.02 | 12.53 | 24.01 | 4.27 |
Free Cash Flow Growth | -54.35% | - | - | -47.80% | 462.20% | -90.08% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 89.24% | 89.18% | 88.34% | 89.84% | 89.38% | 88.24% |
Operating Margin | 23.70% | 30.09% | 26.27% | 26.85% | 27.84% | 11.98% |
Pretax Margin | 27.91% | 33.24% | 30.04% | 32.38% | 35.96% | 19.76% |
Profit Margin | 26.53% | 31.21% | 29.16% | 31.08% | 32.23% | 20.33% |
FCF Margin | 2.05% | 9.93% | -5.38% | 3.38% | 8.14% | 1.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.800 | 0.800 | 0.800 | 0.800 | 0.500 | 0.357 |
Dividend Per Share Growth | 0% | 0% | 0% | 60.00% | 40.02% | 149.90% |
Dividend Yield | 1.10% | 0.75% | 0.75% | 0.66% | 0.40% | 0.20% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 59.99 | 76.15 | 102.35 | 147.63 | 183.98 | 479.01 |
Forward PE | - | 64.08 | 72.92 | 89.59 | 104.25 | 238.22 |
P/FCF Ratio | 779.44 | 239.31 | - | 1356.96 | 728.83 | 5741.55 |
PS Ratio | 15.98 | 23.77 | 29.84 | 45.89 | 59.30 | 97.39 |